| EVUSHELD (cilgavimab / tixagevimab) |
AstraZeneca Canada Inc. |
Treatment |
Authorized |
|
No |
109 |
| Covifenz (virus-like particles (VLP) of SARS-CoV-2 spike protein) |
Medicago Inc |
Vaccine |
Authorized |
|
No |
106 |
| NUVAXOVID (SARS-CoV-2 recombinant spike protein) |
Novavax Inc |
Vaccine |
Authorized |
|
No |
104 |
| PAXLOVID (nirmatrelvir / ritonavir) |
Pfizer Canada ULC |
Treatment |
Authorized |
|
No |
102 |
| Sotrovimab (sotrovimab) |
GlaxoSmithKline Inc |
Treatment |
Authorized By Interim Order |
|
No |
36 |
| Casirivimab and imdevimab (casirivimab / imdevimab) |
Hoffmann-La Roche Limited |
Treatment |
Authorized By Interim Order |
|
No |
34 |
| Janssen COVID-19 Vaccine (Ad26.COV2.S [recombinant]) |
Janssen Inc |
Vaccine |
Authorized By Interim Order |
|
No |
27 |
| COVISHIELD (ChAdOx1-S [recombinant]) Expired September 16 2021 |
Verity Pharmaceuticals Inc/Serum Institute of India (in partnership with AstraZeneca Canada Inc) |
Vaccine |
Authorized By Interim Order |
|
No |
29 |
| Vaxzevria (ChAdOx1-S [recombinant]) previously Astrazeneca Covid-19 Vaccine |
AstraZeneca Canada Inc. |
Vaccine |
Authorized By Interim Order |
|
No |
28 |
| SPIKEVAX (elasomeran) previously COVID-19 Vaccine Moderna |
ModernaTX, Inc. |
Vaccine |
Authorized By Interim Order |
|
No |
15 |
| Comirnaty (tozinameran) previously Pfizer-BioNTech COVID-19 Vaccine |
BioNTech Manufacturing GmbH |
Vaccine |
Authorized By Interim Order |
|
No |
16 |
| Bamlanivimab (bamlanivimab) |
Eli Lilly Canada Inc |
Treatment |
Authorized By Interim Order |
|
No |
8 |
| Veklury (remdesivir) |
Gilead Sciences Canada Inc |
Treatment |
Authorized |
|
No |
9 |
